Seventy-seven subjects between the ages of 18 and 35 years were recruited from Wenzhou Medical University from May 2017 to August 2018. This project was approved by the Ethics Committee of Wenzhou Medical University, and written consent was obtained from all subjects after they were informed about the benefits, risks, and possible adverse consequences of the procedures. The research was performed in compliance with the tenets of the Declaration of Helsinki.
All enrolled subjects underwent a comprehensive ophthalmic examination, including refraction error (noncycloplegic), best corrected visual acuity (BCVA), IOP (by the Full Auto Tonometer TX-F; Topcon, Tokyo, Japan), AL measurement (IOL Master 500; IOLMaster; Carl Zeiss Meditec, Dublin, CA, USA), and fundus photography (Canon EOS 10 SLR backing; Canon, Inc., Tokyo, Japan). Only the right eye of each subject was included for data analysis in this study. None of the subjects had any ocular pathology, history of laser treatment, trauma, or surgery. Subjects who had astigmatism more than −1.00 diopter (D), diabetes, hypertension or other systemic diseases, IOP more than 21 mm Hg, BCVA worse than 20/20, diffuse or severe chorioretinal atrophy, or complications of HM such as retinoschisis and choroidal neovascularization were excluded from the current study. Each subject was assigned to one of three groups based on the spherical equivalent (SE), calculated as the spherical power plus half of the negative cylinder power: (1) the first group served as controls and was composed of eyes with emmetropia and low myopia (EM/LM, SE: +0.50 to −2.75 D); (2) the second group had moderate myopia (MM, SE: −3.00 to −5.75 D); and (3) the third group had HM (SE: ≤ −6.00 D).